Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March.
The item "Price-To-Book-Ratio" stands at 2.37 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Price To Book Ratio" stands at 2.37. This represents an increase of 5.46 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.32 percent compared to the value the year prior.
The 1 year change in percent is 9.32.
The 3 year change in percent is 320.25.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price To Book Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Price To Book Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Price To Book Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Price To Book Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Price To Book Ratio | 280,205,508,085.11 |